Target intelligence / Profile preview

Mediator complex (Mediator)

Target
Mediator
Molecular classification
Multiprotein complex, Transcriptional coactivator, Transcription regulator, Other
01

Overview

The Mediator complex is a large, evolutionarily conserved **multiprotein complex** that acts as a transcriptional coactivator in all eukaryotes[1]. It serves as a critical regulatory hub by physically bridging specific DNA-bound transcription factors with the general RNA polymerase II transcription machinery, thereby enabling regulated expression of nearly all protein-coding genes[1][5][7]. The Mediator complex is structurally modular, comprising at least three main modules (Head, Middle, Tail) and a reversible kinase module (CDK8, MED12, MED13, and Cyclin C) that modulates its activity[3][6][8]. It has both basal and regulatory functions in gene transcription, integrating diverse signaling pathways and effecting epigenetic regulation, mRNA processing, and super-enhancer function[5][7]. Mutations and dysregulation of Mediator subunits are implicated in a range of diseases, including cancer and developmental disorders, highlighting its essential biological and clinical relevance[5][7]. There are currently no approved small molecules or biologics that specifically target the Mediator complex for therapeutic purposes.

Other names
Mediator (coactivator)Mediator transcriptional coactivator complexMED complex
02

Mechanism of action

Not applicable, as there are no clinically approved drugs directly targeting the Mediator complex.

03

Biological functions

Gene transcription activationRegulation of RNA polymerase II transcriptionSignal integration from transcription factorsEpigenetic regulationCell fate and developmental regulationmRNA processingTranscriptional elongationSuper enhancer formation
04

Disease associations

CancerDevelopmental disordersImmune dysregulationOther (expression or mutation of Mediator subunits can associate with various diseases)
05

Safety considerations

Broad targeting of the Mediator complex could disrupt essential gene transcription across multiple cell types, leading to cytotoxicity, developmental arrest, or severe side effects
06

Interacting drugs

None (no approved drugs directly target the Mediator complex in clinical use as of current knowledge)
07

Biomarkers

Altered expression or mutations in specific Mediator subunits (like MED12 or MED13) have been studied as biomarkers in some cancers and developmental disorders, but no broadly established clinical biomarkers

Beyond the preview

Go deeper on Mediator complex (Mediator).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator complex (Mediator).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call